Allergan plc Sees Unusually High Options Volume (AGN)

Allergan plc (NYSE:AGN) was the recipient of unusually large options trading activity on Friday. Traders purchased 8,889 put options on the stock. This represents an increase of approximately 347% compared to the typical volume of 1,990 put options.

Allergan plc (NYSE:AGN) last announced its quarterly earnings data on Tuesday, May 9th. The company reported $3.35 earnings per share (EPS) for the quarter, topping the consensus estimate of $3.32 by $0.03. Allergan plc had a return on equity of 7.21% and a net margin of 100.04%. The firm had revenue of $3.57 billion during the quarter, compared to analysts’ expectations of $3.53 billion. During the same period last year, the business posted $3.04 earnings per share. The company’s revenue for the quarter was up 5.1% compared to the same quarter last year.

The company also recently disclosed a quarterly dividend, which will be paid on Thursday, June 15th. Stockholders of record on Thursday, May 18th will be paid a $0.70 dividend. This represents a $2.80 annualized dividend and a dividend yield of 1.28%. The ex-dividend date of this dividend is Tuesday, May 16th.

In related news, Director Paul Bisaro sold 70,000 shares of the stock in a transaction dated Thursday, March 2nd. The shares were sold at an average price of $246.68, for a total transaction of $17,267,600.00. Following the completion of the transaction, the director now owns 274,226 shares in the company, valued at $67,646,069.68. The transaction was disclosed in a document filed with the SEC, which is available through this link. Corporate insiders own 0.27% of the company’s stock.

Several hedge funds and other institutional investors have recently made changes to their positions in AGN. Crestwood Advisors Group LLC purchased a new position in shares of Allergan plc during the first quarter valued at about $103,000. Sunbelt Securities Inc. bought a new position in shares of Allergan plc during the fourth quarter valued at $107,000. Feltz Wealth PLAN Inc. bought a new position in shares of Allergan plc during the first quarter valued at $107,000. Enterprise Financial Services Corp boosted its position in shares of Allergan plc by 62.7% in the first quarter. Enterprise Financial Services Corp now owns 462 shares of the company’s stock valued at $110,000 after buying an additional 178 shares in the last quarter. Finally, JNBA Financial Advisors boosted its position in shares of Allergan plc by 2.5% in the first quarter. JNBA Financial Advisors now owns 487 shares of the company’s stock valued at $116,000 after buying an additional 12 shares in the last quarter. Hedge funds and other institutional investors own 86.40% of the company’s stock.

Several equities analysts recently weighed in on the stock. Royal Bank of Canada set a $279.00 price target on shares of Allergan plc and gave the company a “buy” rating in a research report on Tuesday, February 14th. Credit Suisse Group AG reiterated a “buy” rating and set a $274.00 target price on shares of Allergan plc in a research report on Tuesday, February 14th. Piper Jaffray Companies set a $205.00 target price on shares of Allergan plc and gave the stock a “hold” rating in a research report on Wednesday, February 22nd. Vetr upgraded shares of Allergan plc from a “hold” rating to a “buy” rating and set a $256.33 target price for the company in a research report on Wednesday, March 1st. Finally, Leerink Swann increased their target price on shares of Allergan plc to $280.00 and gave the stock a “buy” rating in a research report on Thursday, February 9th. Six equities research analysts have rated the stock with a hold rating and fourteen have given a buy rating to the stock. The company has an average rating of “Buy” and an average target price of $267.21.

TRADEMARK VIOLATION WARNING: “Allergan plc Sees Unusually High Options Volume (AGN)” was first published by Markets Daily and is the sole property of of Markets Daily. If you are viewing this article on another website, it was illegally copied and reposted in violation of US & international copyright and trademark law. The original version of this article can be accessed at https://www.themarketsdaily.com/2017/05/20/investors-buy-large-volume-of-allergan-plc-put-options-agn-updated.html.

Allergan plc Company Profile

Allergan, Inc is a multi-specialty healthcare company. The Company focuses on developing and commercializing pharmaceuticals, biologics, medical devices and over-the-counter (OTC) products. It discovers, develops and commercializes a range of products for the ophthalmic, neurological, medical aesthetics, medical dermatology, breast aesthetics, urological and other specialty markets.

12 Month Chart for NYSE:AGN

Receive News & Ratings for Allergan plc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Allergan plc and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply